These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma. Lim WK; Ong CK; Tan J; Thike AA; Ng CC; Rajasegaran V; Myint SS; Nagarajan S; Nasir ND; McPherson JR; Cutcutache I; Poore G; Tay ST; Ooi WS; Tan VK; Hartman M; Ong KW; Tan BK; Rozen SG; Tan PH; Tan P; Teh BT Nat Genet; 2014 Aug; 46(8):877-80. PubMed ID: 25038752 [TBL] [Abstract][Full Text] [Related]
45. Gene Expression Profiling of Fibroepithelial Lesions of the Breast. Li X; Vail E; Maluf H; Chaum M; Leong M; Lownik J; Che M; Giuliano A; Cao D; Dadmanesh F Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240386 [TBL] [Abstract][Full Text] [Related]
46. Association of clinicopathological features and prognosis of TERT alterations in phyllodes tumor of breast. Tsang JYS; Hui YK; Lee MA; Lacambra M; Ni YB; Cheung SY; Wu C; Kwong A; Tse GMK Sci Rep; 2018 Mar; 8(1):3881. PubMed ID: 29497099 [TBL] [Abstract][Full Text] [Related]
47. [Pathological features and clinicopathological significance of TERT promoter mutation in breast fibroepithelial tumors without definite diagnosis]. Wang JG; Hu YJ; Guan JJ; Liu HY; Bi ZJ; Zhang LX; Liu YX; Xing XM Zhonghua Bing Li Xue Za Zhi; 2023 Feb; 52(2):153-159. PubMed ID: 36748136 [No Abstract] [Full Text] [Related]
49. Giant juvenile fibroadenomas with and without prominent pseudoangiomatous stromal hyperplasia (PASH)-like change: clinicopathological and molecular characteristics. Jorns JM; Farooq A; Puzyrenko A; Jarzembowski J; Thike AA; Nasir NDM; Ng CCY; Liu W; Lee JY; Lim AH; Guan P; Teh BT; Tan PH Histopathology; 2023 Sep; 83(3):357-365. PubMed ID: 37140543 [TBL] [Abstract][Full Text] [Related]
50. Comprehensive screening for MED12 mutations in gynaecological mesenchymal tumours identified morphologically distinctive mixed epithelial and stromal tumours. Yuan CT; Huang WC; Lee CH; Lin MC; Lee CH; Kao YC; Huang HY; Kuo KT; Lee JC Histopathology; 2017 May; 70(6):954-965. PubMed ID: 28002623 [TBL] [Abstract][Full Text] [Related]
51. Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis. Tsang JY; Shao Y; Poon IK; Ni YB; Kwan JS; Chow C; Shea KH; Tse GM Pathology; 2022 Oct; 54(6):678-685. PubMed ID: 35691725 [TBL] [Abstract][Full Text] [Related]
52. Audit of fibroepithelial tumors of the breast in a Nigerian tertiary institution. Daramola AO; Oguntunde OA; Awolola NA Niger J Clin Pract; 2016; 19(5):645-8. PubMed ID: 27538554 [TBL] [Abstract][Full Text] [Related]
53. A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions. Tan WJ; Cima I; Choudhury Y; Wei X; Lim JC; Thike AA; Tan MH; Tan PH Breast Cancer Res; 2016 Mar; 18(1):31. PubMed ID: 26961242 [TBL] [Abstract][Full Text] [Related]
54. Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinoma. Meyer B; Stirzaker C; Ramkomuth S; Harvey K; Chan B; Lee CS; Karim R; Deng N; Avery-Kiejda KA; Scott RJ; Lakhani S; Fox S; Robbins E; Shin JS; Beith J; Gill A; Sioson L; Chan C; Krishnaswamy M; Cooper C; Warrier S; Mak C; Rasko JE; Bailey CG; Swarbrick A; Clark SJ; O'Toole S; Pidsley R J Pathol; 2024 Apr; 262(4):480-494. PubMed ID: 38300122 [TBL] [Abstract][Full Text] [Related]
55. The stem cell renewal and DNA damage response pathways are frequently altered in fibroepithelial tumors of breast in Indian patients. Mukherjee N; Islam MS; Roychowdhury A; Bhattacharya R; Chunder N; Bhattacharya N; Sinha S; Alam N; Roy A; Roychoudhury S; Panda CK Pathol Res Pract; 2016 Mar; 212(3):196-203. PubMed ID: 26774289 [TBL] [Abstract][Full Text] [Related]
56. Size and heterologous elements predict metastases in malignant phyllodes tumours of the breast. Koh VCY; Thike AA; Nasir NDM; Yip GWC; Bay BH; Tan PH Virchows Arch; 2018 Apr; 472(4):615-621. PubMed ID: 29127495 [TBL] [Abstract][Full Text] [Related]
57. Fibroepithelial breast lesions diagnosed by core needle biopsy demonstrate a moderate rate of upstaging to phyllodes tumors. Marcil G; Wong S; Trabulsi N; Allard-Coutu A; Parsyan A; Omeroglu A; Atinel G; Mesurolle B; Meterissian S Am J Surg; 2017 Aug; 214(2):318-322. PubMed ID: 28057293 [TBL] [Abstract][Full Text] [Related]
58. Whole-genome profiling helps to classify phyllodes tumours of the breast. Laé M; La Rosa P; Mandel J; Reyal F; Hupé P; Terrier P; Couturier J J Clin Pathol; 2016 Dec; 69(12):1081-1087. PubMed ID: 27207013 [TBL] [Abstract][Full Text] [Related]
59. A study of fibroepithelial tumours of the breast. Badhe BA; Iyengar KR; Alva N Indian J Cancer; 2002; 39(3):91-6. PubMed ID: 12928563 [TBL] [Abstract][Full Text] [Related]
60. Can phyllodes tumours of the breast be distinguished from fibroadenomas using fine needle aspiration cytology? Scolyer RA; McKenzie PR; Achmed D; Lee CS Pathology; 2001 Nov; 33(4):437-43. PubMed ID: 11827409 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]